Why the study?
Does celecoxib compared to meloxicam increase the risk of thromboembolic events in general practice patients?
Does celecoxib compared to meloxicam increase the risk of thromboembolic events in general practice patients?
Celecoxib use is associated with a higher relative risk of cerebrovascular thromboembolic events compared to meloxicam in general practice, though absolute event rates are low.
No takes yet. Share an insight, caveat, or question.
Celecoxib was associated with higher cerebrovascular TE risk than meloxicam; leaves open extension to other events and precludes practice change.
Deborah Layton (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: